4D Molecular Therapeutics, Inc.
FDMT
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$9.23
FAIR PRICE
$8.21
MARGIN
$1.02
P/E Ratio
N/A
Div. Yield
N/A
ROE
-47.3%
Market Cap
$439M
Small-cap
COMING SOON
Get notified when FDMT's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
David H. Kirn
COUNTRY
US
HEADQUARTERS
EmeryVille
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate FDMT's fair price
4D Molecular Therapeutics, Inc.'s fair price of $8.21 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $9.23, FDMT trades 11.1% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting FDMT's risk profile.
RELATIVE · 30%
Comparing FDMT's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for FDMT, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for FDMT.
Explore on BuliosFAQ
What is the fair price of FDMT?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for 4D Molecular Therapeutics, Inc. is $8.21. At the current market price of $9.23, FDMT trades 11.1% above its calculated fair value.
Is FDMT overvalued or undervalued?+
4D Molecular Therapeutics, Inc. is currently overvalued based on our valuation model. The stock trades at $9.23, which is 11.1% above the fair price of $8.21.
How often is FDMT's fair price updated?+
We update fair price calculations for FDMT daily after market close. The current fair price of $8.21 incorporates the latest market data and sector multiples.
What factors affect FDMT's fair price calculation?+
FDMT's fair price of $8.21 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -47.3%.
Is FDMT a good buy right now?+
At $9.23, FDMT trades 11.1% above our fair value estimate of $8.21. The stock is currently overvalued. ROE stands at -47.3% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does FDMT pay dividends?+
FDMT does not currently pay a dividend.